VOLUME 64   2003   NUMBER 3

CME Pretest 229

CME Posttest 347

Brainstorms

230 Neurotransmission of Cognition, Part 3: Mechanism of Action of Selective NRIs: Both Dopamine and Norepinephrine Increase in Prefrontal Cortex. Stephen M. Stahl
[PDF]

Editorial

232 Electroconvulsive Therapy Update: Recognizing and Treating Psychotic Depression. Max Fink
[PDF]

Original Articles

235 Cognitive Impairment: Assessment With Brain Magnetic Resonance Imaging and Proton Magnetic Resonance Spectroscopy. Ulrike Weiss, Reinhard Bacher, Herbert Vonbank, Georg Kemmler, Albert Lingg, and Josef Marksteiner
[Abstract] [PDF]

243 Gepirone Extended-Release: New Evidence for Efficacy in the Treatment of Major Depressive Disorder. Alan D. Feiger, Jon F. Heiser, Ram K. Shrivastava, Kenneth J. Weiss, Ward T. Smith, J. M. A. Sitsen, and Michael Gibertini
[Abstract] [PDF]

250 Efficacy and Tolerability of Paroxetine for the Long-Term Treatment of Generalized Anxiety Disorder. Fabrizio Stocchi, Giampetro Nordera, Riitta H. Jokinen, Ulla M. Lepola, Karen Hewett, Heather Bryson, and Malini K. Iyengar, for the Paroxetine Generalized Anxiety Disorder Study Team
[Abstract] [PDF]

259 The Relationship of Personality Disorders to Treatment Outcome in Depressed Outpatients. Roger T. Mulder, Peter R. Joyce, and Suzanne E. Luty
[Abstract] [PDF]

277 Attitudes of Patients With Schizophrenia Toward Placebo-Controlled Clinical Trials. Martina Hummer, Roswitha Holzmeister, Georg Kemmler, Ursula Eder, Alex Hofer, Ilsemarie Kurzthaler, Maria Oehl, Elisabeth Weiss, and W. Wolfgang Fleischhacker
[Abstract] [PDF]

282 A Randomized, Double-Blind, Placebo-Controlled Study of Classical Homeopathy in Generalized Anxiety Disorder. Omer Bonne, Yair Shemer, Yonatan Gorali, Maor Katz, and Arieh Y. Shalev
[Abstract] [PDF]

288 Divalproex Sodium Versus Olanzapine in the Treatment of Acute Mania in Bipolar Disorder: Health-Related Quality of Life and Medical Cost Outcomes. Dennis A. Revicki, L. Clark Paramore, Kenneth W. Sommerville, Alan C. Swann, and John M. Zajecka, for the Depakote Comparator Study Group
[Abstract] [PDF]

295 Gender Differences in Pathological Gambling. Angela Ibanez, Carlos Blanco, Paula Moreryra, and Jeronimo Saiz-Ruiz
[Abstract] [PDF]

302 Evaluation of Sexual Changes After Stroke. [CME] Salvatore Giaquinto, Sandro Buzzelli, Luciano Di Francesco, and Giuseppe Nolfe
[Abstract] [PDF]

308 Predictors of Quality of Life in Major Psychoses: A Naturalistic Follow-Up Study. Michael Ritsner, Rena Kurs, Anatoly Gibel, Shmuel Hirschmann, Evgeny Shinkarenko, and Yael Ratner
[Abstract] [PDF]

316 Effects of Patient Demographics, Risperidone Dosage, and Clinical Outcome on Body Weight in Acutely Exacerbated Schizophrenia. Hsien-Yuan Lane, Yue-Cune Chang, Yiao-Cheung Cheng, Guang-Chyi Liu, Xing-Ru Lin, and Wen-Ho Chang
[Abstract] [PDF]

321 Depression-Free Days as a Summary Measure of the Temporal Pattern of Response and Remission in the Treatment of Major Depression: A Comparison of Venlafaxine, Selective Serotonin Reuptake Inhibitors, and Placebo. Rajiv Mallick, Jieling Chen, A. Richard Entsuah, and Alan F. Schatzberg
[Abstract] [PDF]

331 Anxiety Disorders in 318 Bipolar Patients: Prevalence and Impact on Illness Severity and Response to Mood Stabilizer.[CME] Chantal Henry, Donatienne Van den Bulke, Frank Bellivier, Bruno Etain, Frederic Rouillon, and Marion Leboyer
[Abstract] [PDF]

Academic Highlights

265 Determining and Achieving Therapeutic Targets in Attention-Deficit/Hyperactivity Disorder. [CME]
[PDF]

Letters To the Editor

336 Mania Associated With Initiation of Ziprasidone. Brock P. Nolan and Jerome J. Schulte, Jr.
[PDF]

336 Burning Mouth Syndrome as a Side Effect of SSRIs. James L. Levenson
[PDF]

• Reply by Giuseppe Maina and Filippo Bogetto

338 Nutritional Approach to Bipolar Disorder. Miles Simmons
[PDF]

• Reply by J. Steven A. Simpson and Bonnie J. Kaplan

339 A Case Report of Olanzapine-Induced Fecal Incontinence. D. N. Mendhekar, P. K. Srivastav, S. K. Sarin, and R. C. Jiloha
[PDF]

339 Adjunctive Quetiapine Treatment of the Polydipsia, Intermittent Hyponatremia, and Psychosis Syndrome: A Case Report. John H. Montgomery and Janet L. Tekell
[PDF]

341 Treatment of Leuprolide-Induced Depression With Intramuscular Testosterone: A Case Report. Marlene P. Freeman and Scott A. Freeman
[PDF]

343 Hydroxyzine for Generalized Anxiety Disorder. Kemal Sagduyu
[PDF]

Book Reviews 344

NOW @ Psychiatrist.com 350

Information for Authors

see July 2002, pages 591-593 or our Web site at www.psychiatrist.com/author.htm